Gastric volvulus associated with shrinkage of a gastrointestinal stromal tumor by neoadjuvant imatinib: a case report
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1752-1947
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Gastric volvulus associated with shrinkage of a gastrointestinal stromal tumor by neoadjuvant imatinib: a case report ; volume:17 ; number:1 ; day:16 ; month:1 ; year:2023 ; pages:1-6 ; date:12.2023
Journal of medical case reports ; 17, Heft 1 (16.1.2023), 1-6, 12.2023
- Creator
-
Sugiyama, Yoichi
Komo, Toshiaki
Tazaki, Tatsuya
Kohyama, Mohei
Takahashi, Shinya
Sasaki, Masaru
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1186/s13256-022-03735-7
- URN
-
urn:nbn:de:101:1-2023032121194590458050
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 10:53 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Sugiyama, Yoichi
- Komo, Toshiaki
- Tazaki, Tatsuya
- Kohyama, Mohei
- Takahashi, Shinya
- Sasaki, Masaru
- SpringerLink (Online service)
Other Objects (12)
A rectal gastrointestinal stromal tumor—a plea for neoadjuvant imatinib and TAMIS
A large esophageal gastrointestinal stromal tumor that was successfully resected after neoadjuvant imatinib treatment: case report
Excision of a Large Gastrointestinal Stromal Tumour Following 16 Months of Neoadjuvant Therapy with Imatinib (Case Report)
Neoadjuvant imatinib treatment and laparoscopic anus-preserving surgery for a large gastrointestinal stromal tumor of the rectum
Inflammation and nutritional status indicators as prognostic indicators for patients with locally advanced gastrointestinal stromal tumors treated with neoadjuvant imatinib
Preoperative imatinib mesylate (IM) for huge gastrointestinal stromal tumors (GIST)
Phase IV Study of Sunitinib in Chinese Patients with Imatinib-Resistant or Imatinib-Intolerant Gastrointestinal Stromal Tumors
Benefit of Continuation of Low-Dose Imatinib for Gastrointestinal Stromal Tumors despite Adverse Events with Regular-Dose Imatinib
Dramatic response of a gastrointestinal stromal tumor to neadjuvant imatinib therapy
Imatinib-Resistant Gastrointestinal Stromal Tumor Presenting as a Large Abdominal Mass
TAS-116 inhibits oncogenic KIT signalling on the Golgi in both imatinib-naïve and imatinib-resistant gastrointestinal stromal tumours
Severe esophagitis in a patient with gastrointestinal stromal tumor treated with imatinib
A rectal gastrointestinal stromal tumor—a plea for neoadjuvant imatinib and TAMIS
A large esophageal gastrointestinal stromal tumor that was successfully resected after neoadjuvant imatinib treatment: case report
Excision of a Large Gastrointestinal Stromal Tumour Following 16 Months of Neoadjuvant Therapy with Imatinib (Case Report)
Neoadjuvant imatinib treatment and laparoscopic anus-preserving surgery for a large gastrointestinal stromal tumor of the rectum
Inflammation and nutritional status indicators as prognostic indicators for patients with locally advanced gastrointestinal stromal tumors treated with neoadjuvant imatinib
Preoperative imatinib mesylate (IM) for huge gastrointestinal stromal tumors (GIST)
Phase IV Study of Sunitinib in Chinese Patients with Imatinib-Resistant or Imatinib-Intolerant Gastrointestinal Stromal Tumors
Benefit of Continuation of Low-Dose Imatinib for Gastrointestinal Stromal Tumors despite Adverse Events with Regular-Dose Imatinib
Dramatic response of a gastrointestinal stromal tumor to neadjuvant imatinib therapy
Imatinib-Resistant Gastrointestinal Stromal Tumor Presenting as a Large Abdominal Mass
TAS-116 inhibits oncogenic KIT signalling on the Golgi in both imatinib-naïve and imatinib-resistant gastrointestinal stromal tumours
Severe esophagitis in a patient with gastrointestinal stromal tumor treated with imatinib
A rectal gastrointestinal stromal tumor—a plea for neoadjuvant imatinib and TAMIS
A large esophageal gastrointestinal stromal tumor that was successfully resected after neoadjuvant imatinib treatment: case report
Excision of a Large Gastrointestinal Stromal Tumour Following 16 Months of Neoadjuvant Therapy with Imatinib (Case Report)
Neoadjuvant imatinib treatment and laparoscopic anus-preserving surgery for a large gastrointestinal stromal tumor of the rectum
Inflammation and nutritional status indicators as prognostic indicators for patients with locally advanced gastrointestinal stromal tumors treated with neoadjuvant imatinib
Preoperative imatinib mesylate (IM) for huge gastrointestinal stromal tumors (GIST)
Phase IV Study of Sunitinib in Chinese Patients with Imatinib-Resistant or Imatinib-Intolerant Gastrointestinal Stromal Tumors
Benefit of Continuation of Low-Dose Imatinib for Gastrointestinal Stromal Tumors despite Adverse Events with Regular-Dose Imatinib
Dramatic response of a gastrointestinal stromal tumor to neadjuvant imatinib therapy
Imatinib-Resistant Gastrointestinal Stromal Tumor Presenting as a Large Abdominal Mass
TAS-116 inhibits oncogenic KIT signalling on the Golgi in both imatinib-naïve and imatinib-resistant gastrointestinal stromal tumours